Pharmacology Matters blog

Our blog is a platform for members and partners to share their views and tell us about their work and interests. If you have any ideas for articles then get in touch.

Affinity groups update - Education and Skills

03 Jan 2018 by Michael Seed, Andrew Webb in Affinity groups published January 2018

For a Society Affinity Group, the Education & Skills Affinity Group is unusual in that it aligns with a British Pharmacological Society committee - the Education and Training Committee chaired by Dr Lisa Wallace and managed by Dr Anna Zecharia, Director of Policy & Public Affairs at the Society. This gives group members important opportunities to inform the Society of pharmacology educators’ needs and concerns, and to advise of developments in innovative practice. It also allows Lisa and Anna direct access to members for ‘on the ground expertise and opinion’.

Editorial - December 2017

21 Dec 2017 by Margaret Cunningham in Editorial published December 2017

In our winter issue of Pharmacology Matters we hear from members from across the world who share their diverse experiences of being part of a global community of pharmacologists.

Young Life Scientists’ Symposium

19 Dec 2017 by Jessica Cegielski in Young pharmacologists published December 2017

The Young Life Scientists’ Symposium is an annual conference supported by the Biochemical Society, British Pharmacological Society and Physiological Society and organised by PhD and Post Doc students for other early career researchers.

Your Society

18 Dec 2017 by Jonathan Bruun published December 2017

In September, we published a report from PricewaterhouseCoopers (PwC) as part of our ongoing Focus on Pharmacology project. The report was commissioned with the intention that it would provide a valuable insight into the educational and career landscape for UK pharmacologists.

Empty columns and or rows devised primarily to confuse?

18 Sep 2017 by Jeffrey Aronson published September 2017

A cruciverbalist (Latin crux = cross and verbum = word) is “A person who compiles or solves crossword puzzles; a crossword enthusiast” (Oxford English Dictionary). The earliest recorded instance dates from 1971. The term “cruxverbalist” appeared in a letter written in 1939, quoted in Alexander Waugh’s family biography Fathers and Sons, but this appears to be a hapax legomenon.

Pharmacology education and employment landscape report launch

12 Sep 2017 by Melisa (Lisa) Wallace, Steven Tucker, Anna Zecharia published September 2017

Today the Society has published a report from PwC showing that pharmacology is alive and well in UK higher education, and that graduates go on to a wide range of successful careers.

Through the eyes of a young pharmacologist: The value of internships and work experience

12 Sep 2017 by Ross King, Laura Humphrys, Sam Groom, Joanna Clarke, Vedia Can in Young pharmacologists published September 2017

The Society’s published report from PwC shows that pharmacology is alive and well in UK higher education, and that graduates go on to a wide range of successful careers. The PwC report also points to the value of internships and work experience and our young pharmacologists agree.

Meet the Medicine Makers

11 Sep 2017 by Teesha Bhuruth, James Brown published September 2017

It all began with the 1962 hit novelty song, Monster Mash by Bobby “Boris” Pickett. In 2009, Dr Steven Rossington from the University of Salford, UK used a Biochemical Society Scientific Outreach Grant to create a giant 3D molecular modelling workshop for schools.

Young Pharmacologists update

04 Sep 2017 by Vedia Can in Young pharmacologists published September 2017

At the British Pharmacological Society, we define a “young pharmacologist” as an Undergraduate, Postgraduate or Early Career member, usually individuals who are no more than five years post-PhD or medical qualification.

Affinity groups update

22 Aug 2017 by David Kendall, Elizabeth Rosethorne, Niall Hyland in Affinity groups published August 2017

The Drug Discovery, Development & Evaluation (DDDE) Affinity Group aims to support members of the Society with interests in all aspects of pharmacology from drug discovery to prescribed use including target identification, drug development, safety pharmacology, conduct of medical research and clinical trials, approval and licensing. DDDE also serves members with interests in natural products and nutraceuticals. Key to this is integrating the interests of members across academic, clinical and industrial settings.

Meetings update

21 Aug 2017 by Niall Hyland, Susanne Schweda in Meetings update published August 2017

At our most recent Focused Meeting, the Society welcomed delegates to the University of Nottingham for a two-day conference organised by the Society’s Drug Discovery, Development and Evaluation Affinity Group co-chairs Professor David Kendall (Pharmnovo AB, UK) and Dr Elizabeth Rosethorne (University of Nottingham, UK).

• >
• 1
• 2
• 3
• 4
• 5
• >